Role of Dach1 in Obesity-Induced Hepatic Insulin Resistance
Description: Project Narrative This project addresses a novel mechanism and consequences of a critical process in the development of type 2 diabetes through targeting a hepatic protein called; Dach1. The project also includes studies using human liver specimens from obese vs. lean human subjects, which will give us the evidence of human relevance to the major components of our hypotheses. Upon completion of the proposed studies, the integrated role of this novel pathway in the setting of obesity could reveal important therapeutic implications.
Funding type: research
Funder scheme: R01
Start date: 2016-07-15
End date: 2022-06-30
Investigator: LALE OZCAN (lead)
Institutions: Columbia University, COLUMBIA UNIVERSITY HEALTH SCIENCES
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Funded outputs count: 9
Funder award ID: R01DK106045
OpenAlex ID: G6859458998
